JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
  会員専用ページ

トップページ
学会案内
沿革
定款
役員・委員会
名誉会員・評議員
学術集会
総会学術集会
歴代総会・学術集会
支部・学術集会
学会教育研修会
国際関連学会
認定制度
リウマチ専門医
リウマチ指導医
教育施設
学会出版物
学会誌MR
NLリウマチ
リウマチ学用語集
会員手続き
本サイトについて
よくある質問
関連リンク集
サイトマップ
プライバシー

MODERN RHEUMATOLOGY Vol.15 No.5

Vol.15 No.5 に戻る

CASE REPORT
Human urinary trypsin inhibitor bolus infusion improved severe interstitial pneumonia in mixed connective tissue disease

Shizuyo Tsujimura1, Kazuyoshi Saito1, Shingo Nakayamada1 and Yoshiya Tanaka1

(1) First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahata-nishi-ku, Kitakyushu 807-8555, Japan

Received: 04 April 2005 Accepted: 21 July 2005

Full Text
  > Click Here (member's only)

Abstract Interstitial pneumonia (IP) with mixed connective tissue disease (MCTD) often progresses despite immunosuppressive therapies that caused serious infections. Human urinary trypsin inhibitor (UT) inhibits inflammatory factors associated with IP, without immunosuppression. UT bolus infusion rescued a female MCTD patient with refractory IP and severe opportunistic fungal pneumonia. Her IP diminished with monthly UT bolus infusion despite tapering of prednisolone, without UT-related side effects. UT pulse therapy could prove beneficial for refractory IP in MTCD even with opportunistic infections.

Key words Human urinary trypsin inhibitor (UT) - Mixed connective tissue disease (MCTD) - Opportunistic infection - Refractory interstitial pneumonia (IP)

 

 
一覧に戻る

Copyright Japan College of Rheumatology All rights reserved.